NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Mesoblast (MESO) Technical (Analysis) Reports Mesoblast ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Mesoblast (MESO)

Technical Analysis Report for USA stock MESO Mesoblast. Dated: 02 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock MESO Mesoblast then click here. or read Experts views on Mesoblast or Forecast & share price targets of Mesoblast

Mesoblast Opened at 14.34 and Closed at: 14.08, which is -1.7% of previous session's close. It moved within a range of 14.01 and 14.34
The session was a Bearish session with an average volume of 265200, which is -25.3% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 7 days back on long term averages

Support for tomorrow is 13.88 and resistance for tomorrow is 14.21
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 13.95, 13.81 resistance for tomorrow's hourly charts is 14.28, 14.47

10 Day SMA for Mesoblast (MESO) is 14.97 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Mesoblast (MESO) is 15.24 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Mesoblast (MESO) is 15.79 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 15.37 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Mesoblast is 15.94 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Mesoblast is at 15.24 and 200 DMA is at 15.94, while 50 DMA and 100 DMA are at 15.79 and 15.37 respectively

Mesoblast (MESO) moving average of 20 SMA is at 15.24 and 20 EMA is at 15.2

Mesoblast (MESO) moving average of 50 SMA is at 15.79 and 50 EMA is at 15.58

Mesoblast (MESO) moving average of 100 SMA is at 15.37 and 100 EMA is at 15.58

Mesoblast (MESO) moving average of 200 SMA is at 15.94 and 200 EMA is at 15.42

China Sxt has performed better than Mesoblast in short term. You could have earned much better returns by investing in China Sxt, about 27.76% more returns!

Mesoblast has performed better than Sutro Biopharma in short term. Holding Mesoblast could be a better choice for now!

Syndax Pharmaceuticals has performed better than Mesoblast in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 4.31% more returns!

Riot Blockchain has performed better than Mesoblast in short term. You could have earned much better returns by investing in Riot Blockchain, about 9.17% more returns!

Orthopediatrics Corp has performed better than Mesoblast in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 17.59% more returns!

Irhythm Technologies has performed better than Mesoblast in short term. You could have earned much better returns by investing in Irhythm Technologies, about 8.39% more returns!

Hutchison China has performed better than Mesoblast in short term. You could have earned much better returns by investing in Hutchison China, about 19.49% more returns!

Fortress Biotech has performed better than Mesoblast in short term. You could have earned much better returns by investing in Fortress Biotech, about 8.63% more returns!

Mesoblast has performed better than Benitec Biopharma in short term. Holding Mesoblast could be a better choice for now!

Mesoblast has performed better than Autolus Therapeutics in short term. Holding Mesoblast could be a better choice for now!

Argenx Se has performed better than Mesoblast in short term. You could have earned much better returns by investing in Argenx Se, about 7.68% more returns!

Accuray Incorporated has performed better than Mesoblast in short term. You could have earned much better returns by investing in Accuray Incorporated, about 22.41% more returns!

Aptevo Therapeutics has performed better than Mesoblast in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 19.86% more returns!

Anika Therapeutics has performed better than Mesoblast in short term. You could have earned much better returns by investing in Anika Therapeutics, about 10.49% more returns!

Mesoblast has performed better than Adial Pharmaceuticals in short term. Holding Mesoblast could be a better choice for now!

Achieve Life has performed better than Mesoblast in short term. You could have earned much better returns by investing in Achieve Life, about 3.99% more returns!

Unitedhealth Group has performed better than Mesoblast in short term. You could have earned much better returns by investing in Unitedhealth Group, about 12.35% more returns!

Penumbra Inc has performed better than Mesoblast in short term. You could have earned much better returns by investing in Penumbra Inc, about 17.28% more returns!

Molina Healthcare has performed better than Mesoblast in short term. You could have earned much better returns by investing in Molina Healthcare, about 13.1% more returns!

Mesoblast Technical analysis of indicators

Price action analysis of Mesoblast (MESO) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Mesoblast stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Mesoblast in short term and the sell signal is strong.

Mesoblast Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Mesoblast in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Mesoblast is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 14.93 and Mesoblast MESO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Mesoblast MESO stock. Volume based technical analysis of Mesoblast MESO stock is negative.

Mesoblast Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock MESO Mesoblast These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And MESO Experts View which covers a lot of information including buying and selling signals

MESO future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Mesoblast or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet